"As a physician, I never imagined I’d one day be facing federal charges for Medicaid fraud. The legal process was overwhelming, isolating, and full of unknowns. I was referred to Sam Mangel by another professional who’d been through a similar experience, and from the first conversation, I knew I’d found the right person to help me navigate what was ahead. Sam didn’t sugarcoat anything. He laid out the reality of my situation with clarity and compassion, the same way that I have always tried to do with my patients. Most importantly, he helped me prepare. From understanding what to expect at sentencing, to walking me through prison designation and the day-to-day realities of federal custody, he was there every step of the way. He even guided my family on how to stay strong and connected during this process. In a system that treats you like a case number, Sam made me feel like a person again. I truly don’t know how I would’ve managed without him. If you’re a professional facing the unimaginable, do not go through it alone. Call Sam."
Claim your business profile now and gain access to all features and respond to customer reviews.
Drawing from his own personal experience with the federal Bureau of Prisons (BOP), Sam Mangel provides a comprehensive and compassionate approach, offering guidance and support to his clients and their families.
Sam specializes in sentence mitigation, helping clients reduce their sentences by as much as 65%. He is also highly experienced in pre-sentence preparation, ensuring that clients are well-prepared for interviews with federal officials, and prison placement, securing favorable designations that minimize hardship. He often works directly with families, offering clear communication on how to maintain connection during incarceration, and guiding them through the complexities of visitations, transfers, and post-release planning.
Sam has successfully worked with some of the highest-profile white collar offenders in recent years and is regularly featured on CNN and in major publications like Bloomberg, the New York Times, Semafor, and Business Insider.See more